INVA Innoviva Inc
Price (delayed)
$18.07
Market cap
$1.13B
P/E Ratio
48.84
Dividend/share
N/A
EPS
$0.37
Enterprise value
$1.28B
Innoviva, Inc. is a healthcare focused asset management company. The Company intends to participate in the development, commercialization and financial management of bio-pharmaceuticals. Innoviva operates in the United States.
Highlights
The gross profit is up by 20% YoY and by 3.8% from the previous quarter
The revenue has grown by 16% YoY
Innoviva's quick ratio has plunged by 71% YoY but it has increased by 34% from the previous quarter
The stock's price to earnings (P/E) is 146% more than its last 4 quarters average of 19.7
INVA's net income has dropped by 87% year-on-year and by 64% since the previous quarter
Key stats
What are the main financial stats of INVA
Market
Valuations
Earnings
Shares outstanding
62.68M
Market cap
$1.13B
Enterprise value
$1.28B
Price to earnings (P/E)
48.84
Price to book (P/B)
1.64
Price to sales (P/S)
3.16
EV/EBIT
21.41
EV/EBITDA
12.83
EV/Sales
3.56
Revenue
$358.71M
Gross profit
$322.11M
Operating income
$163.87M
Net income
$23.39M
EBIT
$59.6M
EBITDA
$99.45M
Free cash flow
$184.52M
Per share
Balance sheet
Liquidity
EPS
$0.37
EPS diluted
$0.36
Free cash flow per share
$2.94
Book value per share
$11.04
Revenue per share
$5.72
TBVPS
$17.13
Total assets
$1.3B
Total liabilities
$609.9M
Debt
$448.34M
Equity
$691.16M
Working capital
$318.22M
Debt to equity
0.65
Current ratio
2.35
Quick ratio
2.11
Net debt/EBITDA
1.44
Margins
Efficiency
Dividend
EBITDA margin
27.7%
Gross margin
89.8%
Net margin
6.5%
Operating margin
45.7%
Return on assets
1.9%
Return on equity
3.4%
Return on invested capital
5.4%
Return on capital employed
5.6%
Return on sales
16.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
INVA stock price
How has the Innoviva stock price performed over time
Intraday
0.72%
1 week
3.73%
1 month
0.84%
1 year
22.09%
YTD
4.15%
QTD
-0.33%
Financial performance
How have Innoviva's revenue and profit performed over time
Revenue
$358.71M
Gross profit
$322.11M
Operating income
$163.87M
Net income
$23.39M
Gross margin
89.8%
Net margin
6.5%
The net margin has plunged by 89% YoY and by 64% from the previous quarter
INVA's net income has dropped by 87% year-on-year and by 64% since the previous quarter
INVA's operating income has soared by 50% YoY and by 4.1% QoQ
The operating margin has increased by 30% YoY and by 2.5% from the previous quarter
Growth
What is Innoviva's growth rate over time
Valuation
What is Innoviva stock price valuation
P/E
48.84
P/B
1.64
P/S
3.16
EV/EBIT
21.41
EV/EBITDA
12.83
EV/Sales
3.56
The stock's price to earnings (P/E) is 146% more than its last 4 quarters average of 19.7
The company's EPS has shrunk by 87% YoY and by 63% QoQ
The P/B is 23% below the 5-year quarterly average of 2.1
The equity has increased by 3.4% since the previous quarter and by 2.4% year-on-year
The revenue has grown by 16% YoY
Efficiency
How efficient is Innoviva business performance
INVA's return on equity has dropped by 89% year-on-year and by 64% since the previous quarter
INVA's ROA has plunged by 88% YoY and by 63% from the previous quarter
The company's return on sales has shrunk by 76% YoY and by 40% QoQ
The return on invested capital has dropped by 71% year-on-year and by 36% since the previous quarter
Dividends
What is INVA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for INVA.
Financial health
How did Innoviva financials performed over time
The total assets is 113% greater than the total liabilities
The company's current ratio has shrunk by 74% YoY but it rose by 31% QoQ
Innoviva's quick ratio has plunged by 71% YoY but it has increased by 34% from the previous quarter
The debt is 35% less than the equity
The equity has increased by 3.4% since the previous quarter and by 2.4% year-on-year
The debt to equity has declined by 3% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.